{"id":4434,"date":"2024-06-16T20:13:55","date_gmt":"2024-06-16T20:13:55","guid":{"rendered":"https:\/\/www.col4a1.net\/?p=4434"},"modified":"2024-06-16T20:19:21","modified_gmt":"2024-06-16T20:19:21","slug":"establishing-foundations-for-translational-interventions","status":"publish","type":"post","link":"https:\/\/www.col4a1.net\/en\/establishing-foundations-for-translational-interventions\/","title":{"rendered":"Establishing foundations for translational interventions"},"content":{"rendered":"

<\/div>
<\/a><\/span><\/div>
<\/div>

Establishing foundations for translational interventions<\/h1><\/div>

<\/h1>\n<\/div>
<\/div>

Dr. Douglas Gould from the Department of Ophthalmology and Anatomy at the Institute for Human Genetics, School of Medicine, University of California, San Francisco, USA, began his presentation titled “Establishing Foundations for Translational Interventions” by thanking the Association for the invitation before diving straight into the core of his talk.<\/p>\n

During his conference, Dr. Gould explored the future of treatments and potential cures for conditions related to Type IV Collagen. He encouraged everyone to imagine where we want to be in 20 years and to outline a clear path to achieve those goals. His presentation focused on three fundamental questions:<\/p>\n